Levosimendan Ideogen 12,5 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung

7680699640027 CH-69964 Konzentrat

Associated product:

LEVOSIMENDAN Ideogen 12,5 mg/5 ml conc perf 12.5 m

No image available

Article details

Package size
4 x 5 ml
Selling units
4
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
levosimendanum
12.5 MG Substance Wirkstoff (Principe actif)
povidonum K 12
- Substance HNIDK
acidum citricum
- Substance HNIDK
ethanolum anhydricum
3847.5 MG Substance HBESI

Authorization holder

IDEOGEN AG

8807 Freienbach

Authorization information

Swissmedic authorization number
69964
Drug name
Levosimendan Ideogen, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
C01CX08
Authorization status
Z
Dispensing category
A
First authorization
13/08/2026
Authorization expiration date
12/08/2031
IT Number
02.05.2.
Domain
Human medicine
Field of application
Akut dekompensierte chronische Herzinsuffizienz

Package details

Description (FR)
LEVOSIMENDAN Ideogen 12,5 mg/5 ml conc perf 12.5 m
Description (DE)
LEVOSIMENDAN Ideogen 12,5 mg/5 ml Konz Inf 12.5 mg
Market launch
02/09/2027
Narcotic (BTM)
No

Other package sizes (1)

LEVOSIMENDAN Ideogen 12,5 mg/5 ml conc perf 12.5 m
1 x 5 ml DUR
GTIN: 7680699640010
View
Buy us a coffee Explore the data